IFNAR1 and neoplasm: Blocking IFN‐α/β receptor (IFNAR) by anti‐IFNAR neutralizing antibody significantly promoted Smad4KO but not WT tumor growth in B6 mice (Figure 4G; Figure S4G, Supporting Information).